Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma
- PMID: 15300888
- PMCID: PMC4572145
- DOI: 10.3748/wjg.v10.i17.2478
Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma
Abstract
Aim: To investigate the potential involvement of leptin in carcinogenesis of hepatocellular carcinoma (HCC) and to elucidate the etiology, carcinogenesis and progress of HCC.
Methods: Expressions of Ob gene product, leptin and its receptor, Ob-R were investigated in 36 cases of HCC specimens and corresponding adjacent non-tumorous liver tissues with immunohistochemical staining. The effect of leptin on proliferation of Chang liver cell line and liver cancer cell line SMMC-7721 was studied with cell proliferation assay (MTT).
Results: Leptin expression was detected in 36 cases of adjacent non-tumorous liver tissues (36/36, 100%) with moderate (++) to strong (+++) intensity; and in 72.22%(26/36) of HCC with weaker (+) intensity (P<0.05). Thirty of 36 (83.33%) cases of adjacent non-tumorous liver tissues were positive for Ob-R, with moderate (++) to strong (+++) intensity. In HCC, 11/36 (30.56%) cases were positive, with weak (+) intensity (P<0.05). In cell proliferation assay, leptin inhibited the proliferation of Chang liver cells. The cell survival rate was 10-13% lower than that of the untreated cells (P>0.05). Leptin had little effect on the proliferation of liver cancer cells (P>0.05).
Conclusion: High level expression and decreased or absent expression of leptin and its receptor in adjacent non-tumorous liver cells and HCC cells, inhibitory effect of leptin on the proliferation of normal Chang liver cells and no effect of leptin on proliferation of liver cancer cells, may provide new insights into the carcinogenesis and progression of human HCC. It could be assumed that leptin acting as an inhibitor and/or promoter, is involved in the process of carcinogenesis and progress of human HCC.
Copyright 2004 The WJG Press ISSN
Figures



Similar articles
-
Leptin in hepatocellular carcinoma.World J Gastroenterol. 2010 Dec 14;16(46):5801-9. doi: 10.3748/wjg.v16.i46.5801. World J Gastroenterol. 2010. PMID: 21155000 Free PMC article. Review.
-
Potential prognostic value of leptin receptor in hepatocellular carcinoma.J Clin Pathol. 2006 Dec;59(12):1267-71. doi: 10.1136/jcp.2005.033464. Epub 2006 Mar 24. J Clin Pathol. 2006. PMID: 16565226 Free PMC article.
-
[Expression of leptin and leptin receptor in hepatocellular carcinoma and the clinicopathological significance].Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):830-3. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21602135 Chinese.
-
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.Hepatology. 2010 Nov;52(5):1713-22. doi: 10.1002/hep.23892. Hepatology. 2010. PMID: 20941777 Free PMC article.
-
Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.Dig Dis Sci. 2017 Jan;62(1):133-142. doi: 10.1007/s10620-016-4365-1. Epub 2016 Dec 5. Dig Dis Sci. 2017. PMID: 27921263
Cited by
-
Primary study of leptin and human hepatocellular carcinoma in vitro.World J Gastroenterol. 2008 May 14;14(18):2900-4. doi: 10.3748/wjg.14.2900. World J Gastroenterol. 2008. PMID: 18473418 Free PMC article.
-
Association between circulating leptin concentration and G-2548A gene polymorphism in patients with breast cancer: a meta-analysis.Arch Med Sci. 2019 Mar;15(2):275-283. doi: 10.5114/aoms.2018.75638. Epub 2018 May 15. Arch Med Sci. 2019. PMID: 30899280 Free PMC article. Review.
-
Leptin in hepatocellular carcinoma.World J Gastroenterol. 2010 Dec 14;16(46):5801-9. doi: 10.3748/wjg.v16.i46.5801. World J Gastroenterol. 2010. PMID: 21155000 Free PMC article. Review.
-
Potential role of leptin expression in hepatocellular carcinoma.J Clin Pathol. 2006 Sep;59(9):930-4. doi: 10.1136/jcp.2005.035477. Epub 2006 Mar 24. J Clin Pathol. 2006. PMID: 16565221 Free PMC article.
-
Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma.Clin Liver Dis. 2011 May;15(2):281-96, vii-x. doi: 10.1016/j.cld.2011.03.007. Clin Liver Dis. 2011. PMID: 21689613 Free PMC article. Review.
References
-
- Sierra-Honigmann MR, Nath AK, Murakami C, García-Cardeña G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, et al. Biological action of leptin as an angiogenic factor. Science. 1998;281:1683–1686. - PubMed
-
- Somasundar P, Yu AK, Vona-Davis L, McFadden DW. Differential effects of leptin on cancer in vitro. J Surg Res. 2003;113:50–55. - PubMed
-
- Onuma M, Bub JD, Rummel TL, Iwamoto Y. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem. 2003;278:42660–42667. - PubMed
-
- Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res. 2001;50:443–459. - PubMed
-
- Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer. 2003;45:1–16. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous